Filing Details
- Accession Number:
- 0000875320-25-000220
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-07 16:23:31
- Reporting Period:
- 2025-08-06
- Filing Date:
- 2025-08-07
- Accepted Time:
- 2025-08-07 16:23:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1735944 | Reshma Kewalramani | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Ceo & President | Yes | Yes | No | No |
Transaction Summary
| Purchased: | 10,000 shares | Avg. Price: $389.58 | Total Value: $3,895,767.70 |
| Number of Shares After Transactions: | 115,968 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-08-06 | 4,290 | $389.08 | 110,258 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-08-06 | 5,710 | $389.95 | 115,968 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- Open market purchases reported on this line occurred at a weighted average price of $389.08 (range $388.71 to $389.43).
- Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
- Open market purchases reported on this line occurred at a weighted average price of $389.95 (range $389.72 to $390.53).
Billionaire Hedge Funds
